- Home
- VTSI vs NRXP Comparison
VTSI vs NRXP Comparison
Compare VTSI & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTSI
- NRXP
- Stock Information
- Founded
- VTSI 1993
- NRXP 2015
- Country
- VTSI United States
- NRXP United States
- Employees
- VTSI N/A
- NRXP N/A
- Industry
- VTSI Miscellaneous manufacturing industries
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- VTSI Consumer Discretionary
- NRXP Health Care
- Exchange
- VTSI Nasdaq
- NRXP Nasdaq
- Market Cap
- VTSI 61.9M
- NRXP 58.5M
- IPO Year
- VTSI N/A
- NRXP N/A
- Fundamental
- Price
- VTSI $6.05
- NRXP $2.92
- Analyst Decision
- VTSI Strong Buy
- NRXP Strong Buy
- Analyst Count
- VTSI 1
- NRXP 5
- Target Price
- VTSI $7.00
- NRXP $31.40
- AVG Volume (30 Days)
- VTSI 49.0K
- NRXP 435.6K
- Earning Date
- VTSI 11-10-2025
- NRXP 11-13-2025
- Dividend Yield
- VTSI N/A
- NRXP N/A
- EPS Growth
- VTSI N/A
- NRXP N/A
- EPS
- VTSI 0.10
- NRXP N/A
- Revenue
- VTSI $27,068,543.00
- NRXP N/A
- Revenue This Year
- VTSI $10.31
- NRXP N/A
- Revenue Next Year
- VTSI $12.71
- NRXP $395.09
- P/E Ratio
- VTSI $61.65
- NRXP N/A
- Revenue Growth
- VTSI N/A
- NRXP N/A
- 52 Week Low
- VTSI $3.57
- NRXP $1.12
- 52 Week High
- VTSI $8.53
- NRXP $6.01
- Technical
- Relative Strength Index (RSI)
- VTSI 54.12
- NRXP 41.65
- Support Level
- VTSI $5.63
- NRXP $3.05
- Resistance Level
- VTSI $6.29
- NRXP $3.32
- Average True Range (ATR)
- VTSI 0.26
- NRXP 0.22
- MACD
- VTSI 0.02
- NRXP -0.05
- Stochastic Oscillator
- VTSI 68.42
- NRXP 0.74
About VTSI VirTra Inc.
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.